Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs

By KATIE THOMAS from NYT Health http://ift.tt/2uvw3P1
via IFTTT
The lawsuit accused the pharmaceutical company of marketing Thalomid and Revlimid for unapproved use on a broader range of cancers.
Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs - By KATIE THOMAS - at Health - Keyword: Drugs (Pharmaceuticals), Suits and Litigation (Civil), Cancer - From The New York Times - Published at July 25, 2017 at 07:00AM